For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Performance & Growth Hormone · Comparison

GHRP-6 vs MGF

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

GHRP-6MGF
CategoryPerformance & Growth HormonePerformance & Growth Hormone
Also known asGrowth Hormone Releasing Peptide-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2Mechano Growth Factor, IGF-1Ec, Insulin-like Growth Factor splice variant
EvidencePreclinical onlyPreclinical only
Dosing range100mcg–300mcg mcg, 1–3 times daily, on an empty stomach100mcg–300mcg mcg, Post-workout (within 30–60 minutes of training), 3–4x weekly
AdministrationSubcutaneous injection, Intramuscular injectionIntramuscular injection (into worked muscle — critical for local effect), Subcutaneous injection (produces more systemic distribution)
Key side effectsStrong increase in appetite (most common and notable), Elevated cortisol and prolactin at higher doses, Water retention / bloating, Fatigue at high dosesLocalized muscle swelling at injection site (normal response), Hypoglycemia (less pronounced than IGF-1 DES but present), Very short half-life means side effects are brief, Potential overuse injury if post-workout injection is used consistently without adequate recovery
Cited sources3 references3 references

Key differences

  • Administration: GHRP-6 — Subcutaneous injection, Intramuscular injection; MGF — Intramuscular injection (into worked muscle — critical for local effect), Subcutaneous injection (produces more systemic distribution).
  • Frequency: GHRP-6 is typically 1–3 times daily, on an empty stomach; MGF is Post-workout (within 30–60 minutes of training), 3–4x weekly.

How each works

GHRP-6

Human studies confirm GHRP-6 robustly elevates GH within 15–30 minutes of injection, with effects diminishing toward baseline within 2–3 hours. Chronic use increases baseline IGF-1. Research also indicates mild stimulation of cortisol and prolactin, particularly at higher doses. Animal models have shown potential cardioprotective, hepatoprotective, and muscle-sparing effects, though human equivalents are not established.

MGF

MGF is encoded by the IGF-1 gene but produced via alternative splicing that generates a unique 49-amino acid C-terminal E-peptide (Ec peptide). The Ec peptide has distinct biological activity from the IGF-1 domain — it directly activates satellite cell proliferation through a receptor pathway separate from the standard IGF-1R. Studies in rodents show that local MGF injection produces significant muscle hypertrophy in the injected limb without systemic IGF-1 elevation. MGF expression spikes within 30 minutes of resistance exercise and declines over 24–48 hours — aligning precisely with the post-exercise anabolic window.

Read the full GHRP-6 profileRead the full MGF profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.